GENERICS REPRESENT 21.5% of the REVENUE of LABORATORIES

The participation of generic drugs on turnover of nine of the ten largest laboratories in the country reached 21.5% in July this year. In units produced, the parcel reached 24.5%, according to PróGenéricos's research, industry association. "In Brazil, as it decreases the resistance of physicians and the general public to generics, the participation grows. The increase in the portfolio also favors, "says the President of the entity, Telma Salles. In 2013, the overall market grew about 9 percent, of 11% advanced generic. Together, the nine laboratories have earned $ 5.9 billion with sales in the segment between August 2013 and July 2014, up 12.3% before the 12 previous months. The value represents 90% of the total revenue of the generics market in the period.